Publication | Open Access
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
73
Citations
7
References
2022
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1